SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ryan Weisman who wrote (566)11/24/1997 12:48:00 PM
From: Frank Buck  Read Replies (1) of 1894
 
AccuMed projected 5 year EPS growth at 50% annualized. The mean earnings per share (EPS) estimate is derived from all polled analysts' estimates of what the company's earnings (profits) per share will be five years from now. Right there with Amazon.Com (AMZN) the internet book seller that has gone ballistic in share price. Why does the buying public believe that Amazon will increase 50% annualy yet acts like they have never heard of AccuMed?

The sector average of 4,024 companies is 19.4%.

Source - Morningstar

morningstar.net

The company??? at least is telling analysts' that they are expecting some robust sales down the pike. Let's hope that these projections are not pie in the sky. In the past two quarters the analysts' appeared to have been given some numbers that have not been in the same ball park that AccuMed has been playing.

Eventually you would think there would be a pleasant quarterly surprise, wouldn't you? Has anyone been in talks with the IR @ ACMI lately to provide some insight to the strength or weakness in sales so far? The second month (in the quarter) is almost closed with one month left for (Q-4-'97). How many hits, runs and errors are we looking at in the bottom of the sixth inning?

Frank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext